#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Erythema multiforme Langerhans cell sarcoma Non-small cell lung cancer Glomerulonephritis chronic Systemic lupus erythematosus Acute graft versus host disease in liver VEXAS syndrome B-cell small lymphocytic lymphoma refractory Bronchiectasis Hyperadrenocorticism Renal cancer metastatic Bone marrow disorder Squamous cell carcinoma of the oral cavity Glomerulonephritis Hormone-dependent prostate cancer More trials…

    Learn about Rare Diseases

    Waldenstrom’s macroglobulinaemia recurrent – Diagnostics Extranodal marginal zone B-cell lymphoma (MALT type) – Trials in Disease Ewing’s sarcoma – Treatment Mucopolysaccharidosis II – Life with Disease Lennox-Gastaut syndrome – Diagnostics Hepatoblastoma – Diagnostics Skin angiosarcoma – Life with Disease Castleman’s disease – Diagnostics Pleural mesothelioma malignant – Basic Information Hereditary neuropathic amyloidosis More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Entrectinib Brimonidine Tartrate Dexpanthenol Ziclumeran Hydralazine Hydrochloride Dronedarone Apocynin Soya Oil, Purified Exenatide Albaconazole Atl001 Fezolinetant GAXILOSE Mexiletine Hydrochloride Murcidencel Rifampicin Pegaspargase Osimertinib Sodium Ascorbate Protein C More therapies…

    Learn about Your Condition

    Anorexia nervosa Tooth loss Oesophageal adenocarcinoma Ocular myasthenia Decreased appetite Synovial sarcoma Deafness neurosensory Uveal melanoma Postprandial hypoglycaemia Pelizaeus-Merzbacher disease Gingival bleeding Pseudoxanthoma elasticum Sciatica Immune system disorder Intellectual disability More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Progressive multiple sclerosis

  • A study testing ACT-1004-1239 compared to placebo for adults with progressive multiple sclerosis to measure nerve repair using MRI scans

    Recruiting

    2 1
    Investigated Diseases:
    • Progressive multiple sclerosis
    Investigated Drugs:
    • ACT-1004-1239
    The Netherlands

  • Study on the Effects of Siponimod for Patients with Secondary Progressive Multiple Sclerosis

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Progressive multiple sclerosis
    Investigated Drugs:
    • Siponimod
    Italy

  • Study on Human Fetal Neural Precursor Cells and Tacrolimus for Patients with Progressive Multiple Sclerosis

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Progressive multiple sclerosis
    Investigated Drugs:
    • Human Neuronal Progenitor/Stem Cells
    • Tacrolimus
    Italy

  • Study on the Effects of Vidofludimus Calcium (IMU-838) in Patients with Progressive Multiple Sclerosis

    Recruiting

    2 1
    Investigated Diseases:
    • Progressive multiple sclerosis
    Investigated Drugs:
    • Vidofludimus Calcium
    Bulgaria Czechia Germany The Netherlands Poland Romania

  • Study on the Effects of Siponimod on Imaging and Immune Markers in Patients with Progressive Multiple Sclerosis

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Progressive multiple sclerosis
    Investigated Drugs:
    • Siponimod
    • Siponimod Fumaric Acid
    Italy

  • Study on Istradefylline for Reducing Brain Inflammation in Patients with Progressive Multiple Sclerosis

    Recruiting

    2 1 1
    Investigated Drugs:
    • Istradefylline
    Finland
1 2
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!